Improving medication safety and diabetes management in hong kong: A multidisciplinary approach

Hong Kong Medical Journal

Volumn 23, Issue 2, 2017, Pages 158-167

  Chung, Agnes Y S ^a   Anand, Shweta ^a   Wong, Ian C K ^b   Tan, Kathryn C B ^c   Wong, Christine F F ^c   Chui, William C M ^c   Chan, Esther W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; HEMATOLOGIC AGENT; HORMONES AND AGENTS ACTING ON THE ENDOCRINE SYSTEM; IMMUNOSUPPRESSIVE AGENT; NON PRESCRIPTION DRUG; RESPIRATORY TRACT AGENT; URINARY TRACT AGENT;

ADVERSE DRUG REACTION; AGED; ARTICLE; ATTITUDE TO HEALTH; DIABETES MELLITUS; DISEASE SEVERITY; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INTERACTION; DRUG USE; FEMALE; HIGH RISK PATIENT; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; NUTRITION; OBSERVATIONAL STUDY; PHARMACIST; POLYPHARMACY; PRESCRIPTION; TREATMENT DURATION; TREATMENT PLANNING; COOPERATION; DISEASE MANAGEMENT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HONG KONG; MEDICATION ERROR; PATIENT CARE; PHARMACY; PREVENTION AND CONTROL; PROFESSIONAL STANDARD; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COOPERATIVE BEHAVIOR; DIABETES MELLITUS; DISEASE MANAGEMENT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HONG KONG; HUMANS; MALE; MEDICATION ERRORS; MEDICATION RECONCILIATION; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE;

EID: 85017200653     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: 10.12809/hkmj165014     Document Type: Article

References (46)

1. International Diabetes Federation International diabetes atlas. 6th ed. Available from: http://www.diabetesatlas.org/resources/previous-editions.html. Accessed Mar 2014.
2. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26:77-82.
3. Tapp H, Phillips SE, Waxman D, Alexander M, Brown R, Hall M. Multidisciplinary team approach to improved chronic care management for diabetic patients in an urban safety net ambulatory care clinic. J Am Board Fam Med 2012;25:245-6.
4. Hellström LM, Bondesson Å, Höglund P, Eriksson T. Errors in medication history at hospital admission: prevalence and predicting factors. BMC Clin Pharmacol 2012;12:9.
5. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30:205-11.
6. Draft statement on pharmaceutical care. ASHP Council on Professional affairs. American Society of Hospital Pharmacists. Am J Hosp Pharm 1993;50:126-8.
7. Pharmaceutical Care Network Europe. The PCNE Classification V 5.01. 2006. Available from: http://www. pcne.org/upload/files/16_PCNE_classification_V5.01.pdf. Accessed 22 Oct 2013.
8. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007;63:187-95.
9. Zaman Huri H, Fun Wee H. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord 2013;13:2.
10. Granas AG, Berg C, Hjellvik V, et al. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci 2010;32:394-403.
11. van Roozendaal BW, Krass I. Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes. Pharm World Sci 2009;31:580-95.
12. Borges AP, Guidoni CM, Ferreira LD, de Freitas O, Pereira LR. The pharmaceutical care of patients with type 2 diabetes mellitus. Pharm World Sci 2010;32:730-6.
13. DeName B, Divine H, Nicholas A, Steinke DT, Johnson CL. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program. J Am Pharm Assoc 2008;48:731-6.
14. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005;39:1828-32.
15. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 2008;28:421-36.
16. Evans CD, Watson E, Eurich DT, et al. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother 2011;45:615-28.
17. Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther 2012;17:57-64.
18. Pepper MJ, Mallory N, Coker TN, Chaki A, Sando KR. Pharmacists’ impact on improving outcomes in patients with type 2 diabetes mellitus. Diabetes Educ 2012;38:409-16.
19. Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012;18:516-26.
20. Jacobs M, Sherry PS, Taylor LM, Amato M, Tataronis GR, Cushing G. Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. J Am Pharm Assoc 2012;52:613-21.
21. Ali M, Schifano F, Robinson P, et al. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med 2012;29:e326-33.
22. Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 2009;67:547-57.
23. Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Ther 2011;36:602-13.
24. Shah M, Norwood CA, Farias S, Ibrahim S, Chong PH, Fogelfeld L. Diabetes transitional care from inpatient to outpatient setting: pharmacist discharge counseling. J Pharm Pract 2013;26:120-4.
25. Heisler M, Hofer TP, Schmittdiel JA, et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation 2012;125:2863-72.
26. Dobesh PP. Managing hypertension in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2006;63:1140-9.
27. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc 2009;49:164-70.
28. Leal S, Soto M. Chronic kidney disease risk reduction in a Hispanic population through pharmacist-based disease-state management. Adv Chronic Kidney Dis 2008;15:162-7.
29. Leung WY, So WY, Tong PC, Chan NN, Chan JC. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med 2005;118:1414.
30. American Pharmacists Association. DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes. J Am Pharm Assoc 2012;52:25-33.
31. Björkman IK, Sanner MA, Bernsten CB. Comparing 4 classification systems for drug-related problems: processes and functions. Res Social Adm Pharm 2008;4:320-31.
32. Eichenberger PM, Lampert ML, Kahmann IV, van Mil JW, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci 2010;32:362-72.
33. Hohmann C, Eickhoff C, Klotz JM, Schulz M, Radziwill R. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability. J Clin Pharm Ther 2012;37:276-81.
34. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary 71. London: British Medical Association, Royal Pharmaceutical Society; 2016.
35. Dean BS, Barber ND. A validated, reliable method of scoring the severity of medication errors. Am J Health Syst Pharm 1999;56:57-62.
36. Haugbølle LS, Sørensen EW. Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma—interviewing patients at home. Pharm World Sci 2006;28:239-47.
37. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999;21:245-50.
38. Song L, Chui WC, Lau CP, Cheung BM. A 3-year study of medication incidents in an acute general hospital. J Clin Pharm Ther 2008;33:109-14.
39. American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013;36 Suppl 1:S11-66.
40. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008;34:692-7.
41. Morello CM, Chynoweth M, Kim H, Singh RF, Hirsch JD. Strategies to improve medication adherence reported by diabetes patients and caregivers: results of a taking control of your diabetes survey. Ann Pharmacother 2011;45:145-53.
42. Perera PN, Guy MC, Sweaney AM, Boesen KP. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). J Manag Care Pharm 2011;17:345-54.
43. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005;27:1104-11.
44. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc 2004;44:337-49.
45. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998;18:1103-11.
46. Chan EW, Taylor SE, Marriott JL, Barger B. Bringing patients’ own medications into an emergency department by ambulance: effect on prescribing accuracy when these patients are admitted to hospital. Med J Aust 2009;191:374-7.